Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegumen Regulatory News (SKIN)

Share Price Information for Integumen (SKIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.775
Bid: 1.70
Ask: 1.85
Change: 0.025 (1.43%)
Spread: 0.15 (8.82%)
Open: 1.75
High: 1.775
Low: 1.75
Yest. Close: 1.75
SKIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Integumen PLC - Exercise of warrants

Wed, 10th Jul 2019 12:55

RNS Number : 1189F
Integumen PLC
10 July 2019
 

 

AIM share code: SKIN

10 July 2019

 

Integumen PLC

 

("Integumen" or "Company")

 

 

Exercise of Warrants

 

Integumen announces that it has received notification from a warrant holder to exercise warrants over 803,572 shares in the share capital of Integumen ("the Warrant Shares"). The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £16,071.44.

 

Total voting rights

 

The Company's total issued share capital, following the issue of the Warrant Shares, will be 977,986,902 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

Integumen plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Vassil Kirtchev

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker

+44 (0) 20 3621 4120

 

About Integumen:

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

 

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSFFFFSFUSEIW
Date   Source Headline
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:36 pmRNSPrice Monitoring Extension
6th May 20207:00 amRNSDoubling of production of Modern Water reagent

Login to your account

Don't have an account? Click here to register.